Financial Advisors Network, Inc. Biogen Inc. Transaction History

Financial Advisors Network, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $1.85 Million - $2.33 Million	-9,548 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $199,512 - $256,403	891 Added 10.29%	9,548 $2.29 Million
Q3 2021 Dec 27, 2021	BUY	$282.99 - $369.05 $587,204 - $765,778	2,075 Added 31.53%	8,657 $2.34 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $67,081 - $107,409	-259 Reduced 3.79%	6,582 $2.28 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $1.66 Million - $1.95 Million	6,841 New	6,841 $1.91 Million

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Financial Advisors Network, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Advisors Network, Inc. with notifications on news.